ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Lorlatinib Exposure‐Response Analyses for Safety and Efficacy in a Phase 1/2 Trial to Support Benefit–Risk Assessment in Non‐Small Cell Lung Cancer
Clinical Pharmacology & Therapeutics
◽
10.1002/cpt.2228
◽
2021
◽
Author(s):
Joseph Chen
◽
Ana Ruiz‐Garcia
◽
Leonard P. James
◽
Gerson Peltz
◽
Holger Thurm
◽
...
Keyword(s):
Lung Cancer
◽
Risk Assessment
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Phase 1
◽
Small Cell
◽
Small Cell Lung
◽
Safety And Efficacy
◽
Exposure Response
◽
Benefit Risk Assessment
Download Full-text
Related Documents
Cited By
References
Crizotinib in patients (pts) with MET-amplified non-small cell lung cancer (NSCLC): Updated safety and efficacy findings from a phase 1 trial.
Journal of Clinical Oncology
◽
10.1200/jco.2018.36.15_suppl.9062
◽
2018
◽
Vol 36
(15_suppl)
◽
pp. 9062-9062
◽
Cited By ~ 34
Author(s):
D. Ross Camidge
◽
Gregory Alan Otterson
◽
Jeffrey W. Clark
◽
Sai-Hong Ignatius Ou
◽
Jared Weiss
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Phase 1
◽
Small Cell
◽
Small Cell Lung
◽
Safety And Efficacy
◽
Phase 1 Trial
Download Full-text
Pralatrexate with Vitamin Supplementation in Patients with Previously Treated, Advanced Non-small Cell Lung Cancer: Safety and Efficacy in a Phase 1 Trial
Journal of Thoracic Oncology
◽
10.1097/jto.0b013e31822adb19
◽
2011
◽
Vol 6
(11)
◽
pp. 1915-1922
◽
Cited By ~ 8
Author(s):
Christopher G. Azzoli
◽
Jyoti D. Patel
◽
Lee M. Krug
◽
Vincent Miller
◽
Leonard James
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Phase 1
◽
Small Cell
◽
Vitamin Supplementation
◽
Small Cell Lung
◽
Safety And Efficacy
◽
Phase 1 Trial
◽
Previously Treated
Download Full-text
A Benefit-Risk Assessment of Erlotinib in Non-Small-Cell Lung Cancer and Pancreatic Cancer
Drug Safety
◽
10.2165/11586540-000000000-00000
◽
2011
◽
Vol 34
(3)
◽
pp. 175-186
◽
Cited By ~ 6
Author(s):
Giannis Mountzios
◽
Kostas N. Syrigos
Keyword(s):
Lung Cancer
◽
Risk Assessment
◽
Pancreatic Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
Benefit Risk Assessment
Download Full-text
A phase 1 study evaluating the safety and efficacy of DKN-01, an investigational monoclonal antibody (Mab) in patients (pts) with advanced non-small cell lung cancer.
Journal of Clinical Oncology
◽
10.1200/jco.2014.32.15_suppl.8068
◽
2014
◽
Vol 32
(15_suppl)
◽
pp. 8068-8068
◽
Cited By ~ 8
Author(s):
William Jeffery Edenfield
◽
Donald A. Richards
◽
Svetislava J. Vukelja
◽
Glen J. Weiss
◽
Cynthia A. Sirard
◽
...
Keyword(s):
Lung Cancer
◽
Monoclonal Antibody
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Phase 1
◽
Small Cell
◽
Small Cell Lung
◽
Phase 1 Study
◽
Safety And Efficacy
Download Full-text
P2-251: Phase 1/2 study evaluating the safety and efficacy of ABT-751 in combination with docetaxel vs docetaxel alone in subjects with advanced or metastatic non-small-cell lung cancer
Journal of Thoracic Oncology
◽
10.1097/01.jto.0000283959.90967.3b
◽
2007
◽
Vol 2
(8)
◽
pp. S672
◽
Cited By ~ 1
Author(s):
Helen Eliopoulos
◽
Nashat Gabrail
◽
Andrew Coates
◽
Xiangdong Zhou
◽
Hao Xiong
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Phase 1
◽
Small Cell
◽
Small Cell Lung
◽
Safety And Efficacy
Download Full-text
A Study to Investigate the Safety and Efficacy of Atezolizumab in Previously-Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Case Medical Research
◽
10.31525/ct1-nct03922997
◽
2019
◽
Author(s):
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Locally Advanced
◽
Small Cell
◽
Small Cell Lung
◽
Safety And Efficacy
◽
Previously Treated Patients
◽
Previously Treated
Download Full-text
A Phase 1/2 Study Evaluating Multiple Nivolumab Combination Therapy in Participants With Stage IV Non-small Cell Lung Cancer That Has Spread or Has Reoccurred After Failure of Chemotherapy and Immunotherapy
Case Medical Research
◽
10.31525/ct1-nct04151563
◽
2019
◽
Author(s):
Keyword(s):
Lung Cancer
◽
Combination Therapy
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Phase 1
◽
Stage Iv
◽
Small Cell
◽
Small Cell Lung
Download Full-text
Faculty Opinions recommendation of Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717964584.793468557
◽
2013
◽
Author(s):
Bruno Andreoni
◽
Gianmarco Contino
Keyword(s):
Lung Cancer
◽
Elderly Patients
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
Safety And Efficacy
◽
First Line Therapy
◽
Line Therapy
Download Full-text
445PD ASCEND-6: single-arm, open label, multicenter phase 1/2 study of ceritinib in Chinese pts with advanced ALK- rearranged (ALK +) non-small cell lung cancer (NSCLC) previously treated with crizotinib
Annals of Oncology
◽
10.1016/s0923-7534(21)00603-7
◽
2016
◽
Vol 27
◽
pp. ix143
Author(s):
L. Zhang
◽
Y. Shi
◽
D.S.W. Tan
◽
B. Hu
◽
L. Xiaoqing
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Phase 1
◽
Small Cell
◽
Small Cell Lung
◽
Open Label
◽
Multicenter Phase
◽
Previously Treated
Download Full-text
Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non–small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study
Lung Cancer
◽
10.1016/j.lungcan.2018.08.019
◽
2018
◽
Vol 125
◽
pp. 273-281
◽
Cited By ~ 26
Author(s):
Shirish M. Gadgeel
◽
James P. Stevenson
◽
Corey J. Langer
◽
Leena Gandhi
◽
Hossein Borghaei
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Phase 1
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
First Line Therapy
◽
Line Therapy
◽
Platinum Based Chemotherapy
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close